Galapagos NV

Galapagos NV is a Belgian biotech focused on oncology and immunology, advancing a pipeline of CAR‑T and small‑molecule therapies with collaborations with Gilead and AbbVie.

Headquarters: Netherlands (NLD)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 704
HQ: Mechelen

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
GLPG	Galapagos NV Cap: 1.9B	EQUITY	AMS	EUR	BE0003818359	Active	📈